155 related articles for article (PubMed ID: 29302191)
1.
Tang W; Wang H; Wang Y; Wang X
Onco Targets Ther; 2018; 11():1-8. PubMed ID: 29302191
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ERCC1 and ERCC2 gene polymorphisms in patients with gastric cancer receiving platinum-based chemotherapy.
Mo J; Luo M; Cui J; Zhou S
Int J Clin Exp Pathol; 2015; 8(11):15065-71. PubMed ID: 26823845
[TBL] [Abstract][Full Text] [Related]
3. Association of ERCC1 rs3212986 & ERCC2 rs13181 polymorphisms with the risk of glioma.
Cui QK; Zhu JX; Liu WD; Wang YH; Wang ZG
Pak J Med Sci; 2014; 30(6):1409-14. PubMed ID: 25674148
[TBL] [Abstract][Full Text] [Related]
4. Systematic review on the association between ERCC1 rs3212986 and ERCC2 rs13181 polymorphisms and glioma risk.
Zhou CX; Zhao JH
Genet Mol Res; 2015 Mar; 14(1):2868-75. PubMed ID: 25867436
[TBL] [Abstract][Full Text] [Related]
5. Association between common polymorphisms in ERCC gene and glioma risk: A meta-analysis of 15 studies.
Qian T; Zhang B; Qian C; He Y; Li Y
Medicine (Baltimore); 2017 May; 96(20):e6832. PubMed ID: 28514298
[TBL] [Abstract][Full Text] [Related]
6.
Deng XD; Ke JL; Chen TY; Gao Q; Zhao ZL; Zhang W; Liu H; Xiang ML; Wang LZ; Ma Y; Liu Y
Front Neurol; 2022; 13():998428. PubMed ID: 36712419
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis.
Zhang L; Wang J; Xu L; Zhou J; Guan X; Jiang F; Wu Y; Fan W
Mutagenesis; 2012 Jan; 27(1):67-76. PubMed ID: 22002622
[TBL] [Abstract][Full Text] [Related]
8. Association of ERCC1 polymorphisms (rs3212986 and rs11615) with the risk of head and neck carcinomas based on case-control studies.
Ding YW; Gao X; Ye DX; Liu W; Wu L; Sun HY
Clin Transl Oncol; 2015 Sep; 17(9):710-9. PubMed ID: 26022132
[TBL] [Abstract][Full Text] [Related]
9. Association of excision repair cross-complimentary group 1 gene polymorphisms with breast and ovarian cancer susceptibility.
Yang F; Mu X; Bian C; Zhang H; Yi T; Zhao X; Lin X
J Cell Biochem; 2019 Sep; 120(9):15635-15647. PubMed ID: 31081240
[TBL] [Abstract][Full Text] [Related]
10. Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis.
Zhu J; Hua RX; Jiang J; Zhao LQ; Sun X; Luan J; Lang Y; Sun Y; Shang K; Peng S; Ma J
PLoS One; 2014; 9(5):e97616. PubMed ID: 24841208
[TBL] [Abstract][Full Text] [Related]
11. Rs3212986 polymorphism, a possible biomarker to predict smoking-related lung cancer, alters DNA repair capacity via regulating ERCC1 expression.
Yu T; Xue P; Cui S; Zhang L; Zhang G; Xiao M; Zheng X; Zhang Q; Cai Y; Jin C; Yang J; Wu S; Lu X
Cancer Med; 2018 Dec; 7(12):6317-6330. PubMed ID: 30453383
[TBL] [Abstract][Full Text] [Related]
12. A miR-15a related polymorphism affects NSCLC prognosis via altering ERCC1 repair to platinum-based chemotherapy.
Xue P; Zhang G; Zhang H; Cui S; Zhang L; Yu T; Xiao M; Li L; Lu X
J Cell Mol Med; 2022 Nov; 26(21):5439-5451. PubMed ID: 36181289
[TBL] [Abstract][Full Text] [Related]
13. Role of common ERCC1 polymorphisms in cisplatin-resistant epithelial ovarian cancer patients: A study in Chinese cohort.
Bao Y; Yang B; Zhao J; Shen S; Gao J
Int J Immunogenet; 2020 Oct; 47(5):443-453. PubMed ID: 32173978
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
Lv Y; Xu M; Sun Y; Liu Y; Zhao L; Liu X; Li Z; Shi G; Jia J; Bi L; Ma N; Zhang X; Qi C
Medicine (Baltimore); 2021 Aug; 100(33):e26850. PubMed ID: 34414935
[TBL] [Abstract][Full Text] [Related]
15. Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
Zhang H; Ge J; Hong H; Bi L; Sun Z
World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
[TBL] [Abstract][Full Text] [Related]
16. Effect of ERCC1 polymorphism on the response to chemotherapy and clinical outcome of non-small cell lung cancer.
Gao H; Ge RC; Liu HY; Wang Y; Yan S
Genet Mol Res; 2014 Oct; 13(4):8997-9004. PubMed ID: 25366790
[TBL] [Abstract][Full Text] [Related]
17. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
Xu TP; Shen H; Liu LX; Shu YQ
Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
[TBL] [Abstract][Full Text] [Related]
18. Distribution and susceptibility of ERCC1/XPF gene polymorphisms in Han and Uygur women with breast cancer in Xinjiang, China.
Li H; Zhou L; Ma J; Zhu Y; Fan J; Li N; Zheng Y; Sha T; Zhai Z; Ma B; Dai Z
Cancer Med; 2020 Dec; 9(24):9571-9580. PubMed ID: 33067872
[TBL] [Abstract][Full Text] [Related]
19. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors.
Geng P; Ou J; Li J; Liao Y; Wang N; Xie G; Sa R; Liu C; Xiang L; Liang H
Mol Neurobiol; 2016 May; 53(4):2705-14. PubMed ID: 26264164
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants in the nucleotide excision repair pathway genes and gastric cancer susceptibility in a southern Chinese population.
He J; Zhuo ZJ; Zhang A; Zhu J; Hua RX; Xue WQ; Zhang SD; Zhang JB; Li XZ; Jia WH
Cancer Manag Res; 2018; 10():765-774. PubMed ID: 29695933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]